Conmed (CNMD) Tops Q4 EPS by 11c, provides guidance Jan 28, 2026 04:07PM
CONMED exits gastroenterology unit, ends Gore distribution deal Dec 5, 2025 08:02AM
Needham Reiterates Hold Rating on CONMED (CNMD) Nov 6, 2025 05:09AM
Conmed (CNMD) Tops Q3 EPS by 3c; offers guidance Nov 5, 2025 04:33PM
Conmed (CNMD) Tops Q2 EPS by 3c ; Offers Guidance Jul 30, 2025 04:07PM


Jul 7, 2025 05:01PM CONMED board member Martha Aronson steps down
Jun 12, 2025 03:53PM Conmed (CNMD) option IV near low end of range as share price down 4.1%
Jun 12, 2025 06:21AM Needham Downgrades CONMED (CNMD) to Hold
May 21, 2025 07:03AM Conmed (CNMD) Appoints LaVerne Council as Chair of the Board of Directors
Apr 30, 2025 04:10PM Conmed (CNMD) Misses Q1 EPS by 21c, provides guidance
Apr 28, 2025 02:15AM Stifel Downgrades CONMED (CNMD) to Hold
Mar 6, 2025 12:45PM BofA Comments on Trump and Mexico Tariff Delay Impact to Medical Technology Names
Feb 25, 2025 07:03AM Conmed (CNMD) Appoints Mark Kaye to its Board
Feb 6, 2025 07:24AM CONMED (CNMD) PT Lowered to $91 at Needham
Feb 6, 2025 03:09AM JPMorgan Downgrades CONMED (CNMD) to Neutral
Feb 5, 2025 04:10PM Conmed (CNMD) Tops Q4 EPS by 13c ; Offers Guidance
Feb 4, 2025 10:03AM Stifel Reiterates Buy Rating on CONMED (CNMD)
Oct 30, 2024 04:24PM Conmed (CNMD) Tops Q3 EPS by 6c, Misses on Revenue; offers FY24 Guidance
Oct 30, 2024 04:02PM Conmed (CNMD) Announces CEO Retirement
Oct 4, 2024 09:04AM Needham Reiterates Buy Rating on CONMED (CNMD)
Oct 4, 2024 08:01AM Conmed (CNMD) Announces Preliminary Third Quarter Financial Information
Aug 1, 2024 07:40AM CONMED (CNMD) PT Lowered to $80 at Piper Sandler
Aug 1, 2024 07:22AM CONMED (CNMD) PT Lowered to $97 at Needham
Jul 31, 2024 04:10PM Conmed (CNMD) Tops Q2 EPS by 7c, provides guidance
Jul 25, 2024 05:45AM CONMED (CNMD) PT Lowered to $106 at Needham